Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0400
-0.0018 (-4.31%)
Jul 2, 2026, 4:00 PM EST
Oncotelic Therapeutics Employees
As of December 31, 2025, Oncotelic Therapeutics had 43 total employees, including 38 full-time and 5 part-time employees. The number of employees increased by 13 or 43.33% compared to the previous year.
Employees
43
Change (1Y)
13
Growth (1Y)
43.33%
Revenue / Employee
n/a
Profits / Employee
$6,033,775
Market Cap
18.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 43 | 13 | 43.33% | 38 | 5 |
| Dec 31, 2024 | 30 | 8 | 36.36% | 26 | 4 |
| Dec 31, 2023 | 22 | 0 | - | 22 | 0 |
| Dec 31, 2022 | 22 | 6 | 37.50% | 22 | 0 |
| Dec 31, 2021 | 16 | 0 | - | 16 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zeo ScientifiX | 20 |
| Inhibitor Therapeutics | 8 |
| ZIVO Bioscience | 7 |
| Provectus Biopharmaceuticals | 6 |
| Anebulo Pharmaceuticals | 3 |
| Galera Therapeutics | 3 |
Oncotelic Therapeutics News
- 4 days ago - Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003 - GlobeNewsWire
- 15 days ago - Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026 - GlobeNewsWire
- 16 days ago - Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services - GlobeNewsWire
- 4 weeks ago - NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Exploration of Nanoparticle, Targeted Drug-Delivery Technologies - GlobeNewsWire
- 4 weeks ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies - GlobeNewsWire
- 4 weeks ago - Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program - GlobeNewsWire
- 4 weeks ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure - GlobeNewsWire
- 4 weeks ago - TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics - GlobeNewsWire